Securities
We're currently building out coverage for Swiss-listed stocks (SIX Swiss Exchange). Other markets will follow.

BB Biotech AG

6y streak
CH0038389992 · BIONSIX · CH · Healthcare · Stock

BB Biotech AG is a Swiss investment company listed on the SIX Swiss Exchange and the Frankfurt Stock Exchange, focused exclusively on investing in listed biotechnology companies worldwide. Its portfolio is concentrated in a select number of firms primarily engaged in the development and commercialization of innovative drugs and therapies. The company is managed by Bellevue Asset Management and pursues a long-term, research-driven investment approach.

Dividend Yield

4.43%

TTM · SIX

Last Dividend

2.25

CHF · 2026-03-23

5Y Growth

-8.97%

CAGR

Frequency

Annual

Years Paid

6

consecutive

Not Cut

1

consecutive yrs

Grown

1

consecutive yrs

Listings

Exchange Ticker Currency Yield TTM
SIX primary
BION CHF 4.43%

Total Return

Starting Amount 10'000 CHF
Price Gain +6'677 CHF
Dividends +739 CHF
Total Return +74.15%
CAGR +74.22%
End Balance 17'415 CHF

Based on 10,000 invested at the start of the period. Price return uses split-adjusted closing prices. Dividends are not reinvested.

Annual Dividends

2026 CHF 2.25
2013
 
2015
 
2017
 
2019
 
2021
 
2023
 
2025
2026

Annual dividend per share · 13 years of data

Advertisement

Dividend Yield History

Loading yield history…
0.0%3.3%6.7%10.0%

Dividend History

Ex-Date Pay-Date Amount Type
23.03.202625.03.20262.25 CHFOrdinary
21.03.202525.03.20251.80 CHFOrdinary
25.03.202427.03.20242.00 CHFOrdinary
27.03.202329.03.20232.85 CHFOrdinary
21.03.202223.03.20223.85 CHFOrdinary
22.03.202124.03.20213.60 CHFOrdinary
25.03.201927.03.20193.05 CHFOrdinary
15.03.201819.03.20183.30 CHFOrdinary
20.03.201722.03.20172.75 CHFOrdinary
21.03.201623.03.20162.25 CHFOrdinary
21.03.201623.03.201612.25 CHFOrdinary
20.03.201524.03.201511.60 CHFOrdinary
21.03.201426.03.20147.00 CHFOrdinary
20.03.201325.03.20134.50 CHFOrdinary